Skip to Content
 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Lung Cancer

    Genetics of lung cancer survival

    Thursday, June 29th, 2017

    African-Americans are more likely to die from lung cancer than whites and yet few studies of possible genetic factors that contribute to this disparity have been conducted. Melinda Aldrich, Ph.D., MPH, and colleagues conducted a first-of-its-kind genome-wide association study of lung cancer survival in 286 African-Americans enrolled in the Southern Community Cohort Study. Reporting recently […]

    Cancer Patient Chooses Nashville for VICC Care and the Nashville Predators

    Friday, June 9th, 2017

    Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville. The first was to support her favorite hockey team, the Nashville Predators, and the second was to meet with Leora Horn, M.D., M.Sc., a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center (VICC). Shaw, 33, […]

    Glowing receptors help find and track cancerous growth

    Friday, May 19th, 2017

    Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth. The molecules are protein receptors that bind epidermal growth factor (EGF). Overexpression of the EGF receptor has been linked to multiple types of cancer. Drugs that block the receptor have become routine treatment […]

    Horn to lead lung cancer combination therapy trial

    Sunday, April 2nd, 2017

    Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer. The Phase 1/2 trial will test the drugs […]

    Team’s discovery offers new insight on lung cancer risk

    Thursday, January 12th, 2017

    Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Their findings, reported recently in the journal JCI Insight, are based on the observation that […]

    VICC trial putting lung cancer therapy to the test

    Thursday, October 20th, 2016

    Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. That head injury may have […]

    VUMC’s Lehman lands LUNGevity research support

    Thursday, September 22nd, 2016

    Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research. The LUNGevity Career Development Awards program bolsters scientists early in their careers to foster […]

    Idrees receives award for cancer outcomes research

    Thursday, July 7th, 2016

    Kamran Idrees, M.D., MSCI, assistant professor of Surgery, has received a Young Investigator Award from the Society of Surgical Oncology Foundation (SSO). The award supports innovative concepts designed to improve health outcomes through advances in the delivery of care. Idrees, who joined the Vanderbilt faculty in 2012, said the one-year award “was an unexpected honor […]

    Superior scan for tumors

    Friday, June 24th, 2016

    While relatively rare, tumors of neuroendocrine cells, which release hormones in response to neuronal signals, have been difficult to diagnose and treat. Now Ronald C. Walker, M.D., and colleagues have reported that PET/CT imaging using the radionuclide Gallium-68 combined with DOTATATE, a compound that binds to these types of tumor cells, is safe and clearly […]

    Lovly tapped to brief Congress on cancer research

    Thursday, June 23rd, 2016

    Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science. The Congressional briefing will be held Tuesday, June 28, on Capitol Hill in Washington, D.C. The event, organized by the […]

    Next Page »

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us